Introduction {#S1}
============

Chronic rhinosinusitis with/without nasal polyps represents a common endpoint in several disease processes [@R01] [@R02].

Factors contributing to rhinosinusitis include infections (viral, bacterial, fungal) muco-ciliary clearance impairment (such as in cystic fibrosis and primary ciliary dyskinesia), immune system defects or dysreactivity such as in allergic rhinitis, intolerance to non-steroid anti-inflammatory drugs (NSAIDs), gastro-oesophageal reflux disease (GERD) and pollution. In each of these cases we can observe, from a histological viewpoint, damage to the respiratory epithelium accompanied by the infiltration of inflammatory cells (predominantly eosinophils, but also neutrophils, mast cells, macrophages and lymphocytes) and subepithelial oedema.

As inflammation, in the broadest sense, should be considered as a protective physiological response to infection and injuries of diverse nature, these inflammatory cells, in turn, release a range of mediators and cytokines: Il-5, IL-8, TNF-α, IFN-γ, RANTES, MBP and ECP are responsible for new recruitment and survival of inflammatory cells, leading to the amplification of the inflammatory process [@R03]. Recently, the importance of the HMG B1 protein in the pathogenesis of several inflammatory diseases has been demonstrated: this protein is released from necrotic/damaged cells [@R04] or immune-activated cells [@R05] and, acting on specific membrane receptors, causes the release of pro-inflammatory mediators, endothelial activation and increased survival of inflammatory cells, mainly eosinophils [@R06].

HMG B1 is an evolutionary ancient protein that is constitutively present in cells, such as leukocytes and epithelial cells, in granules, cytoplasm and nucleus as a deoxyribonucleic acid (DNA)-binding protein with \"alarmin\" activity [@R07]. HMG B1 is actively released in the extra-cellular medium as a late mediator of inflammation by activated macrophages/ monocytes. After stimulation with exogenous bacterial products such as endotoxin, or with endogenous proinflammatory cytokines such as TNF-α and IFN-γ, cultures of macrophages and monocytes actively release HMG B1 in a time- and dose-dependent manner. In addition to its active release, HMG B1 can also be released passively from necrotic or damaged cells including epithelial cells.

Once released in the extracellular medium, HMGB1 has pleomorphic effects including activation of NF-kB, diffuse endothelial activation, epithelial leak and systemic activation of inflammatory cells [@R08].

Recently [@R09], it has been demonstrated that the transcription factor NF-kB is more expressed in NP compared to normal nasal mucosa. This discovery in NP is important both from pathogenic and therapeutic points of view as it is known that NF-kB induces the transcription of cytokines, chemokines and adhesion molecules, which play an important role in the inflammatory process. Moreover, transcription factors influence the response to corticosteroids, which are the basis of NP treatment.

The discovery of HMGB1 protein in the nasal secretions of patients with allergic and non-allergic inflammation of the nose and paranasal sinuses mucosa may contribute to the inflammatory process becoming chronic: in fact, as demonstrated by Ek et al. [@R10] in Sjogren\'s syndrome, HMGB1, together with TNF-α and IL-1β, may form a proinflammatory loop that promotes the chronic inflammation of nasal-sinusal mucosa.

The objectives of the present study were:

1.  To investigate the role of the HMGB1 protein in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP).

2.  To determine whether HMGB1 is increased in chronic rhinosinusitis with nasal polyps (CRSwNP) and is associated with eosinophils, TNF-α and IL5, IL8 cytokines typically expressed in nasal polyps.

3.  To compare the HMGB1 protein in the eosinophil CRSwNP and non-eosinophil CRSwNP.

Materials and methods {#S2}
=====================

The present work originates from an active collaboration among researchers from different Countries and Universities. The protocol was studied to analyze a nuclear protein implicated in the pathogenesis of inflammation. In a first phase, a frequent ORL pathology was examined, but other research is in progress on different inflammatory processes of the ENT district [@R11]. The results have been examined and discussed by all the authors. At the Department of Otolaryngology at Beijing PLA (People Liberation Army) General Hospital, nasal polyps tissue from 21 patients with CRSwNP including 1 patient with asthma and 2 patients with allergic rhinitis and 8 healthy control subjects were collected.

Chronic rhinosinusitis with nasal polyps was confirmed by medical history, nasal endoscopy and computed tomography (CT) scan of the paranasal cavities according to the European Position Paper on rhinosinusitis and nasal polyps [@R03].

The atopic status was evaluated by skin prick test to a standard panel of aeroallergens. The diagnosis of asthma and aspirin sensitivity was based on patient history and physician diagnosis.

Patients with non-invasive fungal sinusitis and invasive fungal disease, chronic obstructive pulmonary disease or systemic disease, such as congenital mucociliary diseases, cystic fibrosis or severe asthma were excluded.

Individual symptoms of chronic rhinosinusitis (including nasal congestion, nasal discharge or postnasal drip, headache or facial pain and hyposmia) were evaluated on a scale of 0-10 before surgery. Nasal endoscopic examination was graded with the Lund-Kennedy classification [@R12]; CT scans of paranasal cavities were graded with the Lund-Mackay classification [@R13]. Control subjects were patients with rhinorrhoea of cerebrospinal fluid, fracture of the optic canal or a benign skull base tumour and did not have a history of sinus disease or asthma. Clinical characteristics of patients and control subjects are reported in [Table I](#T1){ref-type="table"}.

###### 

Clinical characteristics of study participants.

                                                             Control subjects   CRSwNP       p value                                      
  ---------------------------------------------------------- ------------------ ------------ ------------ ---------- --- --- --- ---- --- ----
  No. of subjects                                            8                  10           11           --                              
  Sex (male/female)                                          5/3                8/2          8/3          NS                              
  Mean age(y), median range                                  37(22-70)          42 (30-54)   38 (17-56)   NS                              
  Nasal congestion                                           1                  9            11           \< 0.001                        
  Rhinorrhoea                                                0                  9            9            0.001                           
  Headache                                                   1                  6            3            NS                              
  Facial pain/pressure                                       0                  1            1            NS                              
  Hyposmia                                                   0                  8            6            0.014                           
  No. of bilateral polyps                                    0                  10           4            NS                              
  Recurrent history                                          0                  2            3            NS                              
  Atopy                                                      Y                  N            U            Y          N   U   Y   N    U   NS
  0                                                          4                  4            2            5          3   0   5   6        
  Asthma                                                     0                  8            0            1          9   0   0   11   0   
  Increased eosinophils[^\*^](#T1FN7){ref-type="table-fn"}   0                  8            3            0.005                           
  Increased lymphocytes[^\*^](#T1FN7){ref-type="table-fn"}   0                  2            1            NS                              

CRSwNP: chronic rhinosinusitis with nasal polyps;

Eos: eosinophilic;

Non-Eos: non eosinophilic;

N: No;

Y: yes;

U: unknown

In peripheral blood

Biopsy specimens of nasal mucosa and nasal polyps (II degree according to the Lund Kennedy grading system) were collected before surgery. Samples were subjected to haematoxylin-eosin (HE) staining and immunohistochemistry to investigate HMGB1 protein expression and its correlation with eosinophils and IL-5, IL-8 and TNF-α cytokines. Part of fresh tissue was snap-frozen at -180° for immunohistochemical staining.

According to HE staining, subjects were divided into three groups: 8 control subjects, 10 eosinophilic CRSwNP patients and 11 non-eosinophilic CRSwNP patients. The degree of the infiltrating eosinophils was counted in 10 high power (HP) fields (x400 magnification). A patient was classified as Eos CRSwNP when the eosinophils in the specimen showed more than 10 eosinophils per HP field. Symptom scores, nasal endoscopic examination and CT results in eosinophil CRSwNP and non-eosinophil CRSwNP analysis are reported in [Table II](#T2){ref-type="table"}.

###### 

CT scans, nasal endoscopic examination and symptoms score analysis in Eos CRSwNP and non-Eos CRSwNP (mean ± SD).

                     Eos CRSwNP non-   non-Eos CRSwNP   p value
  ------------------ ----------------- ---------------- ---------
  MS                 2.40 ± 0.70       2.00 ± 0.78      NS
  AES                3.20 ± 1.03       2.00 ± 1.61      NS
  PES                2.60 ± 0.97       1.36 ± 1.29      0.023
  SS                 2.20 ± 1.03       0.91 ± 1.04      0.010
  FS                 2.40 ± 1.17       1.64 ± 1.43      NS0
  OMCS               3.60 ± 0.70       2.55 ± 1.64      NS
  ES                 5.80 ± 1.75       3.27 ± 2.76      0.023
  TS                 16.40 ± 4.17      10.45 ± 6.92     0.030
  Endoscopy          3.40 ± 1.35       2.36 ± 1.43      NS
  Nasal congestion   7.6 ± 1.58        6.64 ± 2.46      NS
  Rhinorrhoea        5.30 ± 2.63       4.82 ± 3.13      NS
  Headache           3.80 ± 2.70       1.27 ± 2.24      0.032
  Hyposmia           7.00 ± 2.16       3.27 ± 3.58      0.010
  VAST               23.70 ± 5.21      15.91 ± 7.57     0.014

MS: Maxillary sinus score; AES: Anterior ethmoid sinus score; PES: Posterior ethmoid sinus score; SS: Sphenoid sinus score; FS: Frontal sinus score; OMCS: Ostiomeatal complex score; ES: Total ethmoid sinus score; TS: Total CT score; VAST: Visual analogue scale total

Immunohistochemical staining {#S2a}
----------------------------

Biopsy samples were sectioned (7 μm) in a cryostat after fixation and dehydration. Sections were placed on chromegelatin-coated slides and air dried for 10 min permeabilized in PBS. Endogenous peroxidase activity was blocked with 3% H2O2 for 10 min at room temperature in the dark. The slides were rinsed three times in PBS for 2 min before blocking for 20 min with 10% normal horse serum in PBS. Slides were incubated with a HMG B1 rabbit polyclonal antibody (ab-18256, dilution 1:300), IL -5 mouse monoclonal antibody (ab25034, dilution 1:200), TNF-α mouse monoclonal antibody (ab1793, dilution 1:200) or IL -8 goat polyclonal antibody (ab10769, dilution 1:200) (Abcam, Cambridge, USA) at 4° overnight in a humidified chamber. Slides were then rinsed three times in PBS for 5 min. The secondary antibody was PV-9000 Kit or PV-9003. Finally, slides were developed with a diaminobenzidine kit (ZSJQ) for 10 min. Slides were counterstained with Mayer\'s haematoxylin and mounted using neutral resin. Negative control slides were probed with PBS and normal rabbit serum (normal mouse serum) under the same experimental conditions.

All statistical analyses were performed using SPSS13.0 software. Data are presented as the mean ± SEM unless otherwise noted. One-way repeated measures ANOV A with post hoc multiple comparisons using LDS method were used to compare means among groups. For nonparametric data, differences between two groups were analyzed by the Mann-Whitney U test. Correlations were assessed by using the Pearson correlation or Spearman rank correlation. Multivariate regression analysis was undertaken to evaluate the relationship between HMGB1 protein expression and eosinophils, IL-5, IL-8, TNF-α positive cells.

A p value less than 0.05 was considered statistically significant.

Results {#S3}
=======

In [Figure 1](#F1){ref-type="fig"}, haematoxylin-eosin stained sections from control subjects, patients with eosinophil chronic rhinosinusitis with nasal polyps and patients with non-eosinophil chronic rhinosinusitis with nasal polyps are shown.

![Haematoxilin-eosin stained sections (x40).](0392-100X-32-386-g001){#F1}

[Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} show immunohistochemically stained sections for HMGB1, Il-5, IL-8 and TNF-α in control subjects, patients with eosinophil chronic rhinosinusitis with nasal polyps and patients with non-eosinophil chronic rhinosinusitis with nasal polyps. Immunohistochemical staining revealed that HMGB1 protein was widely detectable in both controls and patients with CRSwNP. The degree of HMGB1 protein expression was evaluated by dividing the stained sections in 4 portions: 1) nucleus of epithelial cells, 2) cytoplasm of epithelial cells, 3) focal extracellular infiltration, 4) inflammatory cells.

![Immunohistochemical staining for HMGB1 and IL-5 (x40).\
Immunolocalization of HMGB1 in nasal polyposis. Immunohistochemical staining revealed that HMGB1 protein is widely detectable in both controls and patients with CRSwNP, and is expressed in the nucleus and cytoplasm.Il-5 is detectable in the subepithelial layer of patients with CRSwNP.Black arrows show HMGB1 expression in epithelial cells, while red arrows show focal infiltration in subepithelial layers.](0392-100X-32-386-g002){#F2}

![Immunohistochemicalstaining staining for IL-8 and TNF-α (x40).\
Il-8 and TNF-α are detectable in the subepithelial layer of patients with CRSwNP, but not in controls.](0392-100X-32-386-g003){#F3}

HMGB1 was more expressed in the nucleus of epithelial cells of patients compared with controls, and the difference was statistically significant between controls and patients with non-eosinophil CRSwNP. In contrast, epithelial cytoplasm HMGB1 staining was significantly lower in patients with eosinophil CRSwNP and non-eosinophil CRSwNP.

Subepithelial focal infiltration of HMGB1 protein expression was lower in controls and in patients with eosinophil chronic rhinosinusitis with nasal polyps.

Expression of HMG B1 in inflammatory cells in patients with both eosinophil and non-eosinophil chronic rhinosinusitis with nasal polyps was significantly increased compared to the controls. Semi-quantitative analysis of this data is represented as box plots in [Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}.

![Semiquantitative analysis of cells staining positive for HMGB1 protein presented as box plots.\
Data are presented as box plots, where the boxes represent the 25th to 75th percentiles, the line within the boxes represent the median and the lines outside the boxes represent the minimum and maximum values. P values are compared among groups.\
\* *p* \< 0.05; \*\* *p* \< 0.01; \*\*\* *p* \< 0.001](0392-100X-32-386-g004){#F4}

![Semiquantitative analysis of cells staining for eosinophils, IL-5, IL-8 and TNF-α.\
Data are presented as box plots, where the boxes represent the 25th to 75th percentiles, the line within the boxes represent the median, and the lines outside the boxes represent the minimum and maximum values. P values are compared among groups.\
\* *p* \< 0.05; \*\* *p* \< 0.01; \*\*\* *p* \< 0.001](0392-100X-32-386-g005){#F5}

When exploring the correlation between HMGB1 protein expression in different portions and the number of eosinophil infiltrating cells, or IL-5, IL-8 and TNF-α positive cells in patients with CRSwNP and controls, a significant positive correlation was found between expression in the nucleus of epithelial cells and eosinophils, IL-5, IL-8 and TNF-α. A positive correlation was also found between HMGB1 expression in the cytoplasm of epithelial cells and eosinophils, and the expression in inflammatory cells and IL-8 positive cells ([Figs. 6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}).

![Multivariate regression analysis between HMGB1 protein expression and eosinophils, and IL-5 and IL-8 positive cells.](0392-100X-32-386-g006){#F6}

![Multivariate regression analysis between HMGB1 protein expression and TNF-α positive cells.](0392-100X-32-386-g007){#F7}

Conclusions {#S4}
===========

Chronic rhinosinusitis with or without nasal polyposis is a clinical syndrome characterized by persistent inflammation of the mucosa of the nose involving secondly the sinus mucosa. Whereas there is no evidence for a causal correlation between nasal anatomic variations and the incidence of CRS, and as the inflammation is observed mainly at the interface with the external environment, the hypothesis that CRS results from a defective or excessive immune response to foreign agents with persistent inflammatory cells influx has been recently postulated 14. In the last decades, due to the difficulty in understanding the aetiologic factors and pathogenic mechanisms, CRSwNP was considered as a multifactorial disease. The real innovation of the \"immune and mechanical barrier\" hypothesis is that it focuses on host susceptibility as the main factor for CRS with/without nasal polyposis and does not on a single microbial or environmental factor.

The mechanical barrier of the sinus mucosa consists of ciliated cells, goblet cells and respiratory epithelial cells linked by tight junctions. Ciliated and goblet cells are entrusted with the mucociliary transport first line of defense against foreign materials and microbial agents. Breakdown of the mechanical components of the epithelial barrier plays an important role in permitting microbial colonization and foreign proteins to stimulate an immune response.

It has been recently demonstrated that in addition to the physical barrier, sinonasal epithelial cells play an active role in both the innate and acquired immune response [@R15]. On airway epithelial cells [@R16]^-^[@R18], pattern recognition receptors (PRRs) that recognize pathogen associated molecular patterns (PAMPs) have been identified; recognition of PAMPs by host epithelial cells through PRRs results in the release of innate protective agents as well as chemokines and cytokines that attract innate cellular defenses. In addition to PAMPs, cells also sense cellular damage through damage-associated molecular patterns (DAMPs) [@R19].

Among DAMPs, HMGB1 was recognized three decades ago, and has been identified in patients affected by inflammatory processes of the lower airways [@R20].

Our study showed that the HMGB1 protein is increased in the nucleus of epithelial cells, or as focal subepithelial infiltration and in inflammatory cells in patients with CRSwNP; HMGB1 protein is decreased in the cytoplasm of epithelial cells. We did not find a significant difference in HMGB1 expression between Eos CRSwNP and non-Eos CRSwNP, suggesting that HMGB1 may play a crucial role in the pathogenesis of chronic rhinosinusitis with nasal polyps independently of the aetiologic stimuli. Eosinophils and IL-5, IL-8 and TNF-α positive cells may be involved in the regulation of HMGB1.

Obviously, these results warrant further studies to determine the mechanisms and the relative importance of the HMGB1 protein in the pathogenesis of CRSwNP.
